Literature DB >> 21681432

Association between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients.

Carla G Rasuck1, Sinara M O Leite, Flavia Komatsuzaki, Alessandro C S Ferreira, Vanessa C Oliveira, Karina B Gomes.   

Abstract

Colorectal cancer (CRC) corresponds to the third most prevalent type of cancer. Its origins can either be sporadic or inherited, being Lynch syndrome the most common form of hereditary CRC. The activation of BRAF oncogene, inactivation of mismatch repair genes by methylation of CpG islands, and microsatellite instability (MSI) have been reported to be involved in CRC development. The goal of the study was to characterize CRC tumors using clinical and molecular criteria through association and cluster analysis. Amsterdam II and Bethesda guidelines and molecular variables were analyzed in 77 patients from Brazil. The replication error (RER) status, based in microsatellite instability, showed association with metachronous tumor, MLH1 gene methylation and inverse association with left-sided and synchronous tumors. The PMS2 gene was considered the best predictor for differentiating levels of methylation and the mononucleotide were considered the best markers to evaluate RER status. The cluster 1 was characterized of individuals over 60 years of age, female, right-sided tumor, high microsatellite instability, and metachronous or synchronous tumors. The individuals in cluster 2 were younger than 45 years of age, male and showed left sided or rectum tumors, and microsatellite stability. Even though it was not observed a significant association, a higher number of individuals with family history of cancer and tumors without promoter methylation were found in cluster 2. The V600E mutation did not show association with clinical or molecular characteristics. Evaluation of MSI and methylation of MLH1 and PMS2 genes should be considered in order to assist with clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681432     DOI: 10.1007/s11033-011-1007-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  45 in total

Review 1.  DNA mismatch repair genes and colorectal cancer.

Authors:  J M Wheeler; W F Bodmer; N J Mortensen
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E.

Authors:  Anne Jarry; Damien Masson; Elisabeth Cassagnau; Sigrid Parois; Christian Laboisse; Marc G Denis
Journal:  Mol Cell Probes       Date:  2004-10       Impact factor: 2.365

3.  The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients.

Authors:  A Fariña-Sarasqueta; G van Lijnschoten; E Moerland; G-J Creemers; V E P P Lemmens; H J T Rutten; A J C van den Brule
Journal:  Ann Oncol       Date:  2010-05-25       Impact factor: 32.976

4.  CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.

Authors:  Shuji Ogino; Katsuhiko Nosho; Gregory J Kirkner; Takako Kawasaki; Jeffrey A Meyerhardt; Massimo Loda; Edward L Giovannucci; Charles S Fuchs
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

5.  MMR gene expression pattern in sporadic colorectal cancer.

Authors:  Mihai Ioana; Cristina Angelescu; Florin Burada; Francisc Mixich; Anca Riza; Theodor Dumitrescu; Dragos Alexandru; Tudorel Ciurea; Mihai Cruce; Adrian Saftoiu
Journal:  J Gastrointestin Liver Dis       Date:  2010-06       Impact factor: 2.008

Review 6.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

7.  Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.

Authors:  Patrícia Koehler-Santos; Patricia Izetti; Jamile Abud; Carlos Eduardo Pitroski; Silvia Liliana Cossio; Suzi Alves Camey; Cláudio Tarta; Daniel C Damin; Paulo Carvalho Contu; Mario Antonello Rosito; Patricia Ashton-Prolla; João Carlos Prolla
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

8.  BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.

Authors:  Guoren Deng; Ian Bell; Suzanne Crawley; James Gum; Jonathan P Terdiman; Brian A Allen; Brindusa Truta; Marvin H Sleisenger; Young S Kim
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

9.  Mutational analysis of the BRAF gene in human tumor cells.

Authors:  Masatsugu Ueda; Eisaku Toji; Osamu Nunobiki; Shinji Izuma; Yoshiaki Okamoto; Kiyo Torii; Sadamu Noda
Journal:  Hum Cell       Date:  2008-05       Impact factor: 4.174

10.  Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.

Authors:  Georgia Thodi; Florentia Fostira; Raphael Sandaltzopoulos; George Nasioulas; Anastasios Grivas; Ioannis Boukovinas; Maria Mylonaki; Christos Panopoulos; Mirjana Brankovic Magic; George Fountzilas; Drakoulis Yannoukakos
Journal:  BMC Cancer       Date:  2010-10-11       Impact factor: 4.430

View more
  9 in total

1.  The role of EGFR monoclonal antibodies (MoABs) cetuximab/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer.

Authors:  Shan Muhammad; Zheng Jiang; Zheng Liu; Kavanjit Kaur; Xishan Wang
Journal:  J Gastrointest Oncol       Date:  2013-03

Review 2.  Extent of field change in colorectal cancers with BRAF mutation.

Authors:  Aaron Poh; Heidi Sian Ying Chang; Kok Yang Tan; Xin Xiu Sam; Avery Khoo; Shoa Nian Choo; Min En Nga; Wei Keat Wan
Journal:  Singapore Med J       Date:  2017-02-17       Impact factor: 1.858

3.  Lynch Syndrome Associated Colon Adenocarcinoma Resembling Lymphoma on Fluoro-Deoxyglucose-Positron Emission Tomography/Computed Tomography.

Authors:  Carina Mari Aparici; Aung Zaw Win
Journal:  World J Nucl Med       Date:  2015 Sep-Dec

4.  Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.

Authors:  Masayuki Nagahashi; Toshifumi Wakai; Yoshifumi Shimada; Hiroshi Ichikawa; Hitoshi Kameyama; Takashi Kobayashi; Jun Sakata; Ryoma Yagi; Nobuaki Sato; Yuko Kitagawa; Hiroyuki Uetake; Kazuhiro Yoshida; Eiji Oki; Shin-Ei Kudo; Hiroshi Izutsu; Keisuke Kodama; Mitsutaka Nakada; Julie Tse; Meaghan Russell; Joerg Heyer; Winslow Powers; Ruobai Sun; Jennifer E Ring; Kazuaki Takabe; Alexei Protopopov; Yiwei Ling; Shujiro Okuda; Stephen Lyle
Journal:  Genome Med       Date:  2016-12-22       Impact factor: 11.117

5.  A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

Authors:  Benedito Mauro Rossi; Edenir Inêz Palmero; Francisco López-Kostner; Carlos Sarroca; Carlos Alberto Vaccaro; Florencia Spirandelli; Patricia Ashton-Prolla; Yenni Rodriguez; Henrique de Campos Reis Galvão; Rui Manuel Reis; André Escremim de Paula; Luis Gustavo Capochin Romagnolo; Karin Alvarez; Adriana Della Valle; Florencia Neffa; Pablo German Kalfayan; Enrique Spirandelli; Sergio Chialina; Melva Gutiérrez Angulo; Maria Del Carmen Castro-Mujica; Julio Sanchez de Monte; Richard Quispe; Sabrina Daniela da Silva; Norma Teresa Rossi; Claudia Barletta-Carrillo; Susana Revollo; Ximena Taborga; L Lena Morillas; Hélène Tubeuf; Erika Maria Monteiro-Santos; Tamara Alejandra Piñero; Constantino Dominguez-Barrera; Patrik Wernhoff; Alexandra Martins; Eivind Hovig; Pål Møller; Mev Dominguez-Valentin
Journal:  BMC Cancer       Date:  2017-09-05       Impact factor: 4.430

6.  Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer.

Authors:  Binbin Xie; Bingjun Bai; Yuzi Xu; Yunlong Liu; Yiming Lv; Xing Gao; Fei Wu; Zhipeng Fang; Ying Lou; Hongming Pan; Weidong Han
Journal:  Signal Transduct Target Ther       Date:  2019-11-29

7.  Prevalence of the BRAF p.v600e variant in patients with colorectal cancer from Mexico and its estimated frequency in Latin American and Caribbean populations.

Authors:  Jesús Arturo Hernández-Sandoval; Melva Gutiérrez-Angulo; María Teresa Magaña-Torres; Carlos Rogelio Alvizo-Rodríguez; Helen Haydee Fernanda Ramírez-Plascencia; Beatriz Armida Flores-López; Jesús Alonso Valenzuela-Pérez; Jorge Peregrina-Sandoval; José Miguel Moreno-Ortiz; Mev Domínguez-Valentín; María de la Luz Ayala-Madrigal
Journal:  J Investig Med       Date:  2020-03-16       Impact factor: 2.895

8.  Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.

Authors:  Shailesh Mahesh Advani; Pragati Shailesh Advani; Derek W Brown; Stacia M DeSantis; Krittiya Korphaisarn; Helena M VonVille; Jan Bressler; David S Lopez; Jennifer S Davis; Carrie R Daniel; Amir Mehrvarz Sarshekeh; Dejana Braithwaite; Michael D Swartz; Scott Kopetz
Journal:  BMC Cancer       Date:  2019-10-17       Impact factor: 4.430

9.  The Sensitivity and Specificity of Novel Primers for Detection of BRAFV600E Mutation.

Authors:  Bizhar A Tayeb; Howard J Pringle
Journal:  Asian Pac J Cancer Prev       Date:  2020-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.